Page 4 - Sam Gandy News Today

A new Alzheimer’s drug is hitting the market with experts voicing a lot of caution.

A new Alzheimer’s drug is hitting the market with experts voicing a lot of caution.

It's a long-needed new treatment, but experts also are voicing a lot of caution

Here are some things to know about the FDA's approval of lecanemab, to be sold under the brand name Leqembi.

A new Alzheimer’s drug is hitting the market — the first with clear-cut evidence that it can slow, by several months, the mind-robbing disease.

A new Alzheimer’s drug is hitting the market — the first with clear-cut evidence that it can slow, by several months, the mind-robbing disease.

Here are some things to know about the FDA's approval of lecanemab, to be sold under the brand name Leqembi.

Here are some things to know about the FDA's approval of lecanemab, to be sold under the brand name Leqembi.

Here are some things to know about the FDA's approval of lecanemab, to be sold under the brand name Leqembi.

Here are some things to know about the FDA's approval of lecanemab, to be sold under the brand name Leqembi.